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CASE REPORT / OLGU SUNUMU
Anesthetic management in VACTERL syndrome
VACTERL sendromunda anestetik yaklaşım
İlker Öngüç Aycan1, Hüseyin Turgut2, Zeynep Baysal Yıldırım1, Gönül Ölmez Kavak1
ÖZET
Çoklu  konjenital  malformasyonlardan  dolayı  VACTERL 
sendromunda anestezi yönetimi vertebra, kardiyak, tra-
kea-özefageal, renal ve ekstremite anomalileri nedeniyle 
bir çok problemi içermektedir. Bu yazıda trakeo-özefageal 
fistül nedeniyle opere olan VACTERL sendromlu hasta-
mızdaki anestezi öncesi değerlendirme, premedikasyon, 
anestezi  indüksiyonu  ve  devamı  ile  postoperatif  izlemi 
içeren anestezi yönetimimizi sunmayı amaçladık. 
Anahtar kelimeler: VACTERL sendromu, anestezi, ke-
tamin
ABSTRACT
VACTERL Syndrome consists of many problems regard-
ing to anesthesia management due to multiple congeni-
tal malformations which may include vertebral, cardiac, 
trachea-osephageal, renal and limb anomalies. Here we 
present our anesthetic management -in terms of preanes-
thetic  evaluation,  premedication,  induction  and  mainte-
nance of anesthesia and postoperative follow up- in a 
newborn  patient  with  VACTERL  Syndrome  undergoing 
tracheo-eosophagial fistula operations. J Clin Exp Invest 
2014; 5 (1): 103-105
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INTRODUCTION
VACTERL  syndrome  contains  vertebral  defects 
(v), anal atresia (A), cardiac defects (C), tracheo-
esophageal  fistula  (TE),  renal  malformations  (R), 
and limb abnormalities (L). All major malformations 
in acronym is not necessary to diagnose a new-
born’s VACTERL syndrome. At least three of these 
congenital malformations provide the diagnosis of 
the VACTERL syndrome [1-3]. Due to multiple con-
genital anomalies of different systems, anesthesia 
management of these patients can be complicated. 
In this case report, we present our anesthetic expe-
rience in a newborn with VACTERL syndrome oper-
ated due to tracheo-esophageal fistula.
CASE REPORT
A newborn male infant weighted 2300 gram was 
born by caesarean section and there was no rela-
tionship between his parents. Newborn’s operation 
was immediately planned due to tracheo-eosoph-
agial fistula. VACTERYL syndrome was diagnosed 
in our patient because of tracheosophageal fistula, 
esophagus atresia, pes equinovarus and posterior 
uretral valve patterns. 
Before operation, cystostomy was opened due 
to posterior urethral valve. Preoperative examina-
tion was normal except rhonchus findings in chest 
oscultation.  Laboratory  evaluation  revealed  BUN: 
17 mg/dL, creatinine: 0,7 mg/dL, glucose: 62 mg/
dL,  potassium:  3,1  mmol.dL-1,  Na:  141  mg.dL-1, 
calcium: 8,5 mg.dL-1, AST: 78 U.L-1, ALT: 7 U.L-1, 
total protein: 5,5 g.dL-1, albumine: 2,7 g.dL-1, bili-
rubin: 3,2 mg.dL-1, indirect bilirubin: 2,9 mg.dL-1, 
WBC: 11,9 K.UL-1, hemoglobin: 18,4 g.dL-1, hema-
tocrit: 50%, platelet: 328 K.UL-1, International Nor-
malized Ratio (INR): 1,22, activated partial throm-
boplastin time (aPTT): 49,8 seconds and because 
of the fact that disordered coagulation parameters, 
46 cc fresh frozen plasma was given. Control val-
ues was INR: 1,05, aPTT: 28 seconds. The patient 
was  operated  after  giving  184  cc.24hour-1  1/3 
izodeks (Eczacıbaşı-Baxter®, İstanbul) and 9.6 cc. 
24hour-1  total  parenteral  nutritional  support.  An-
tibiotic therapy was administered by giving 35 mg 
amicasin once a day and 55 mg ampicillin twice a Aycan et al. Anesthetic management in VACTERL syndrome 104
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day. Patient was operated at 24th hour of caesar-
ean  section.  Standard  anesthesia  monitorization 
(three lead electrocardiography (EKG), SpO2, heat, 
non-invasive blood pressure (NIBP)) was applied to 
patient. It was seen that SpO2 was %65, heart rate 
was 130 beats.min-1, NIBP was 67/34 mm.Hg-1. 
Patient had multiple organ anomaly. Premedication 
was done by giving 100 µg atropin after then an-
esthesia induction was done by giving 2 mg.kg-1 
ketamine, 0,1 mg.kg-1 midazolam. Rocuronium 0.5 
mg/kg was used in order to achieve rapid intubation 
with minimal mask ventilation. 
Following anesthesia induction patient was in-
tubated with 3.0 number endotracheal tube by the 
expert anesthetist. Ventilation was maintained with 
pressure  support  mode,  respiration  rate  was  50 
breath.min-1 and airway pressure was set at 15 cm-
H2O. Anesthesia was maintained with 0,75 mg.kg-1 
iv bolus ketamine in every 30 minutes and %60-40 
O2-air gas mixture. During the operation, SpO2 was 
between  95-100%,  heart  rate  was  between  100-
120 beats.min-1, NIBP was between 59/27-71/35 
mmHg, and etCO2 was between 36-55 mmHg. Op-
eration was ended in 130 minutes. After 10 minutes 
from the end of the operation, spontaneous respi-
ration began and patient was monitored in sponta-
neous mode. The patient’s SpO2 was between 93-
95% with 60-40% O2-air gas mixture. However, the 
patient was not extubated due to the decrease of 
saturation in room air. 
Patient  transferred  to  the  neonatal  intensive 
care unit as intubated. In postoperative second day 
patient was ventilated with pressure support mode 
followed by t tube technic. At postoperative third day 
all pharyngeal reflexes was fully reversed, adequate 
spontaneous breathing effort was established and 
the patient was extubated uneventfully. Postopera-
tive 4th day patient was sent to service and patient 
was discharged at postoperative 7th day.
DISCUSSION
Patients with VACTERL syndrome have a combina-
tion of many different repeated operations thanks 
to having many anomalies. Patients’ prognosis be-
comes better with advances in surgical techniques 
[1]. However, VACTERL syndrome has risk in terms 
of anaesthesia due to having many anomalies. The 
risk  of  aspiration  increases  in  VACTERL  patients 
depending on regurgitation and tracheo-eosopha-
gial fistula [4]. In order to prevent regurgitation and 
aspiration  we  made  premedication  with  atropine, 
fast induction and intubation with rocuronium. The 
induction method which we used is correlated with 
methods used in previous reports.
There  have  been  reported  no  difference  be-
tween inhaled anesthetic agents in literature. Khat-
avkar [4] reported that 8-year-old patient with VAC-
TERL syndrome who had been operated more than 
one was operated for cataract surgery and given 
halothane Mariano and his friends [5] informed in 
their case report that a newborn baby was operat-
ed due to VACTERL syndrome and isoflurane was 
used in anesthesia. Also, Yıldız and et all [2] used 
sevoflurane  to  patient  with  VACTERL  syndrome. 
We  prefer  intravenous  anesthesia  with  ketamine 
combined with atropine premedication in order to 
prevent  laryngoscopy  induced  vagal  stimulation 
and bradycardia which had been showed an effec-
tive method in newborns by Barois et all [6]. Barois 
et all showed that immediate ketamine analgesia 
plus atropine for tracheal intubation was effective in 
terms of decreasing pain and preventing vagal stim-
ulation induced bradycardia. Also we used atropine 
premedication before induction in order to prevent 
ketamine induced hipersalivation. 
Cardiac malformations have been reported in 
approximately  40-80%  of patients  with  VACTERL 
association [7]. The most common cardiac anomaly 
in VACTERL syndrome is ventricular septal defect 
22.3% [8]. Patients may also present with Tetralogy 
of Fallot, patent ductus arteriousus and atrial sep-
tal defect [8]. In our patient there was no cardiac 
anomaly and patient was haemodinamically stable 
during operation.
As findings are so variable in patients with VAC-
TERL syndrome, each patient be carefully evaluat-
ed individually and anesthetic approach should be 
preferred according to the patient.
Our  patient  has  no  cardiac  anomaly  which 
might complicate our anesthesia management how-
ever we take all cautions in order to prevent pos-
sible hemodynamical disturbances, risk of regurgi-
tation and aspiration. According to our experience 
we can conclude that anaesthesiologist should pre-
fer  anesthesia  management  according  to  patient 
health conditions, risk factors and type of surgical 
treatment.  Close  monitorization  is  also  crucial  in 
perioperative and postoperative periods.
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